NCT04146519

Parkinson's Disease Therapy Using Cell Technology

Developent and Implement a Method of Parkinson's Disease Therapy Using Cell Technology

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Belarusian Medical Academy of Post-Graduate Education · Academic / Other
• Sex: All
• Age: 18 Years – 69 Years
• Healthy volunteers: Not accepted

Summary

Treatment of patients with Parkinson's disease using mesenchymal stem cells is a perspective method to influence on the pathogenesis of the disease. At the same time, this is a complex and still insufficiently explored process. Autologous mesenchymal stem cells will be transplanted to 30 patients with Parkinson's disease. The results of the effectiveness of the combined and intravenous routes of mesenchymal stem cells administration on the motor and non-motor symptoms in these patients will be evaluated and compared with the results of control group that received placebo therapy

Conditions

• Transplantation:Mesenchymal Stem Cell Transplantation

Interventions

Type	Name	Description
BIOLOGICAL	Autologous mesenchymal stem cells	Autologous mesenchymal stem cells
OTHER	Placebo	Saline solution

Timeline

• Start date: 2017-07-01
• Primary completion: 2021-12-01
• Completion: 2021-12-31
• First posted: 2019-10-31
• Last updated: 2021-03-03

Locations

1 site across 1 country: Belarus